Health
State of Health Brazil results show China's Sinovac vaccine is just 50.4 percent effective against COVID-19
Just Earth News | @justearthnews | 14 Jan 2021, 09:56 pm Print
China COVID-19 Vaccine Brazilian clinical trials have unveiled that a COVID-19 vaccine developed by China's Sinovac has been found to be 50.4% effective, media reports said.
It shows the vaccine is significantly less effective than previous data suggested - barely over the 50% needed for regulatory approval, reports BBC.
The vaccine is one of the two which the Brazilian government has lined up.
Brazil is one of the worst-hit COVID-19 nations in the world.
Sinovac, a Beijing-based biopharmaceutical company, is behind CoronaVac, an inactivated vaccine. It works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response, reports BBC.
More Health
- From thinning to thriving? New hair loss treatment is showing promising results in trials
- Surprising coffee link: Daily cups may slow ageing in severe mental illness
- Malaria crisis looms as WHO reveals explosive rise in drug resistance
- Study shows nanoplastics from bottles are not just pollution—They may be harming you from within
- Are birth control pills affecting your mental health? New study raises red flags
-1763561110.jpg "Image of the day: November 19, 2025")
